Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.59 - $1.04 $25,498 - $44,946
43,218 Added 6.5%
707,828 $417,000
Q1 2024

May 13, 2024

BUY
$0.61 - $0.83 $48,191 - $65,572
79,003 Added 13.49%
664,610 $471,000
Q4 2023

Feb 13, 2024

BUY
$0.42 - $0.86 $22,047 - $45,144
52,494 Added 9.85%
585,607 $474,000
Q3 2023

Nov 13, 2023

BUY
$0.58 - $0.91 $81,915 - $128,522
141,234 Added 36.04%
533,113 $330,000
Q4 2022

Feb 13, 2023

SELL
$0.73 - $14.6 $690 - $13,811
-946 Reduced 0.24%
391,879 $317,000
Q2 2022

Aug 12, 2022

BUY
$1.33 - $2.31 $104,389 - $181,307
78,488 Added 24.97%
392,825 $640,000
Q1 2022

May 13, 2022

SELL
$1.26 - $2.52 $78,295 - $156,590
-62,139 Reduced 16.51%
314,337 $716,000
Q4 2021

Feb 11, 2022

SELL
$2.33 - $5.94 $67,441 - $171,933
-28,945 Reduced 7.14%
376,476 $877,000
Q3 2021

Nov 12, 2021

BUY
$5.89 - $9.35 $151,484 - $240,472
25,719 Added 6.77%
405,421 $2.39 Million
Q2 2021

Aug 13, 2021

BUY
$9.16 - $19.51 $371,639 - $791,559
40,572 Added 11.96%
379,702 $3.48 Million
Q1 2021

May 12, 2021

BUY
$10.64 - $14.7 $1.87 Million - $2.59 Million
176,051 Added 107.95%
339,130 $4.56 Million
Q4 2020

Feb 12, 2021

BUY
$9.32 - $13.63 $155,765 - $227,798
16,713 Added 11.42%
163,079 $1.81 Million
Q3 2020

Nov 13, 2020

BUY
$8.59 - $11.89 $24,447 - $33,838
2,846 Added 1.98%
146,366 $1.39 Million
Q2 2020

Aug 13, 2020

BUY
$7.23 - $12.1 $241,250 - $403,752
33,368 Added 30.29%
143,520 $1.67 Million
Q1 2020

May 14, 2020

BUY
$5.9 - $13.8 $44,668 - $104,479
7,571 Added 7.38%
110,152 $908,000
Q4 2019

Feb 13, 2020

BUY
$6.51 - $12.23 $322,765 - $606,363
49,580 Added 93.55%
102,581 $1.25 Million
Q3 2019

Nov 12, 2019

BUY
$6.45 - $8.44 $230,297 - $301,350
35,705 Added 206.44%
53,001 $397,000
Q2 2019

Aug 14, 2019

BUY
$6.16 - $14.15 $106,543 - $244,738
17,296 New
17,296 $116,000

Others Institutions Holding HOOK

About HOOKIPA Pharma Inc.


  • Ticker HOOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,654,500
  • Market Cap $155M
  • Description
  • HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...
More about HOOK
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.